Clinical Trials Browser

Phase EARLY_PHASE1 × Unknown × pembrolizumab × Clear all

NCT03099564 2023-02-06

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Phase EARLY_PHASE1 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT03371992 2020-03-27

NO3DEXPL

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung